Daniel Vitt - Jan 3, 2022 Form 4 Insider Report for IMMUNIC, INC. (IMUX)

Role
Chief Executive Officer, Director
Signature
/s/ Daniel Vitt
Stock symbol
IMUX
Transactions as of
Jan 3, 2022
Transactions value $
$0
Form type
4
Date filed
1/6/2022, 03:02 PM
Previous filing
Aug 11, 2021
Next filing
Jun 6, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMUX Stock Option Award $0 +215K $0.00 215K Jan 3, 2022 Common Stock 215K $10.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months.